KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Non-Current Debt: 2018-2024

Historic Non-Current Debt for Elanco Animal Health (ELAN) over the last 7 years, with Dec 2024 value amounting to $4.3 billion.

  • Elanco Animal Health's Non-Current Debt fell 8.14% to $4.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 billion, marking a year-over-year decrease of 8.14%. This contributed to the annual value of $4.3 billion for FY2024, which is 25.44% down from last year.
  • Latest data reveals that Elanco Animal Health reported Non-Current Debt of $4.3 billion as of FY2024, which was down 25.44% from $5.7 billion recorded in FY2023.
  • Over the past 5 years, Elanco Animal Health's Non-Current Debt peaked at $6.0 billion during FY2021, and registered a low of $4.3 billion during FY2024.
  • Over the past 3 years, Elanco Animal Health's median Non-Current Debt value was $5.4 billion (recorded in 2022), while the average stood at $5.2 billion.
  • In the last 5 years, Elanco Animal Health's Non-Current Debt surged by 139.09% in 2020 and then fell by 25.44% in 2024.
  • Over the past 5 years, Elanco Animal Health's Non-Current Debt (Yearly) stood at $5.6 billion in 2020, then grew by 8.13% to $6.0 billion in 2021, then fell by 9.58% to $5.4 billion in 2022, then rose by 5.29% to $5.7 billion in 2023, then dropped by 25.44% to $4.3 billion in 2024.